SCHEMBL371923

SCHEMBL371923

CCC(O)(Cl)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071193 0.74 TET2 (0.35)
SCHEMBL6678513 0.73 TSHR (0.44)
SCHEMBL1495773 0.73
SCHEMBL1320969 0.73
Oxalic Acid SCHEMBL30172492 0.73 ALDH1A1 (0.37)
SCHEMBL1708069 0.73
SCHEMBL11050416 0.73
SCHEMBL28035228 0.72 ALDH1A1 (0.38)
SCHEMBL3367518 0.72 ALDH1A1 (0.38)
SCHEMBL4612927 0.71 FDPS (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324682-A1 Medical stent provided with inhibitors of atp synthesis INTERSTITIAL THERAPEUTICS (CH) 2009-12-31 US claimed
EP-1789029-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION Interstitial Therapeutics (CH) 2007-05-30 EP claimed
EP-1789030-A2 MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS Interstitial Therapeutics (CH) 2007-05-30 EP claimed
EP-1789107-A2 MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS Interstitial Therapeutics (CH) 2007-05-30 EP claimed
WO-2006024489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024488-A2 MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024491-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024492-A2 MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
EP-2595973-B1 A PROCESS FOR THE PRODUCTION OF CARNITINE FROM BETA-LACTONES LONZA AG (CH) 2017-07-12 EP disclosed
US-9394238-B2 Process for the production of carnitine from β-lactones LONZA LTD. (CH) 2016-07-19 US disclosed
CN-103003257-B For being produced the method for carnitine by β-lactone LONZA LTD. (CH) 2016-03-16 CN disclosed
US-20150126775-A1 PROCESS FOR THE PRODUCTION OF CARNITINE FROM BETA-LACTONES LONZA LTD. (CH) 2015-05-07 US disclosed
EP-2595951-B1 A PROCESS FOR THE PRODUCTION OF CARNITINE LONZA AG (CH) 2014-04-16 EP disclosed
US-8563752-B2 Process for the production of carnitine by cycloaddition LONZA LTD. (CH) 2013-10-22 US disclosed
WO-2006024489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO disclosed
WO-2006024488-A2 MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO disclosed
US-5155043-A Assymetric hydrolysis of halohydrin-containing esters or carboxylic acids with specific microorganisms IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-10-13 US disclosed
EP-0391345-A2 Method for preparing optically active substances IDEMITSU KOSAN COMPANY LIMITED (JP) 1990-10-10 EP disclosed
EP-0142929-B1 WATER SOLUBLE POLYMERS AND METHODS OF USE THEREOF BETZ EUROPE, INC. (US) 1989-06-07 EP disclosed
EP-0142929-A2 Water soluble polymers and methods of use thereof BETZ EUROPE, INC. (US) 1985-05-29 EP disclosed